PatientPartner and Mark Cuban Cost Plus Drug Company Team Up

April 20 12:30 2023
The collaboration enables PatientPartner to display and invite their current patient community to engage with Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs), and will enable Cost Plus Drugs to display and promote PatientPartner to their network of patients who currently use their service to find the most cost-effective drug solutions.

Both PatientPartner and Cost Plus Drugs take a patient-centric approach and challenge the status quo of the traditional healthcare system by providing a needed resource to understand each individual and their unique healthcare needs. All this is done while simultaneously optimizing the patients’ pathway back to a healthy lifestyle.

By providing transparency into the available therapies, both organizations strive to improve the quality of life for patients, physically and financially. PatientPartner was designed to help patients find a solution for their health condition by providing peer-to-peer insight into various therapies/solutions from someone who has gone through that treatment.

“The partnership between our two organizations has the opportunity to impact millions of lives and truly give patients a new resource for healthcare.  Through our shared patient-first approach, I have confidence this will be a massive success for both companies,” says the CEO of PatientPartner, George Kramb.

The same excitement and passion are present across the board at Mark Cuban Cost Plus Drugs. 

“We are excited to work with PatientPartner to bring lower prescription drug prices to consumers,” said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company. “Cost Plus Drugs and PatientPartner share a common goal of providing consumers the lowest possible price for their prescription medication. With Cost Plus Drugs, consumers can be confident they are getting a fair price and the convenience of medication mailed directly to their homes.” The relationship allows for a wider pool of patients to become aware of the services they have at their disposal, to improve their quality of life while bringing empathy back into healthcare through shared experiences and support.  

About PatientPartner

Founded in 2017, PatientPartner is a health technology platform that allows pre-treatment patients to connect with experienced patients, also known as mentors, to gain insight into a specific type of therapy/treatment. The product is free for patients, and the organization donates to charity for every mentor connection on the platform. The PatientPartner technology is disease-state-agnostic and works with medical device and pharmaceutical companies, as well as physician practices, to drive peer-to-peer engagement, which leads to a better understanding of their products and services.  

About Mark Cuban Cost Plus Drugs

The Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) aims to fundamentally change the way the pharmaceutical industry operates. As a public-benefit corporation, its social mission of improving public health is just as important as the bottom line. Cost Plus Drugs transparently charges a standard markup on every drug it sells. The online pharmacy launched in January 2022 now carries over 1,000 prescription products, delivered by mail to thousands of happy customers every day. Cost Plus Drugs is working with health plans, managed-care organizations, pharmacy benefits managers (PBMs), and self-insured employers to bring these same savings to employer-sponsored benefit plans nationwide. If you would like to offer Cost Plus Drugs low-cost medications to your company or organization, please contact us at or at

Media Contact
Company Name: Otter PR
Contact Person: Chandni Desai
Email: Send Email
Phone: 8136786828
Address:320 1st Ave N Suite 110
City: St. Petersburg
State: Florida
Country: United States